CD8A and neoplasm: Consistent with priming of tumor-specific CD8+ T cells identified in TdLN of 4T1 tumor-bearing mice, ISIM increased the frequency of Tet+ CD8+ T cells in PB and the tumor compared with untreated mice (Fig. 1h).